Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Employee Benefits Expense - Narrative (Details)

v3.22.1
Employee Benefits Expense - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Disclosure of attribution of expenses by nature to their function [line items]      
Employee benefits $ 212,153 $ 130,979 $ 73,608
Capitalized employee costs 34,000 43,000 36,000
Cost of sales      
Disclosure of attribution of expenses by nature to their function [line items]      
Employee benefits 62,300 34,500 3,700
Platform and Application Expense      
Disclosure of attribution of expenses by nature to their function [line items]      
Employee benefits 6,900 8,800 7,200
Research and Development Expense      
Disclosure of attribution of expenses by nature to their function [line items]      
Employee benefits 42,900 53,300 36,600
Selling, general and administrative expense      
Disclosure of attribution of expenses by nature to their function [line items]      
Employee benefits $ 100,095 $ 34,362 $ 26,020